{"version":"1.0","provider_name":"Dr. Nathan Ehrlich, N.D.","provider_url":"https:\/\/drnat.com\/nd","author_name":"NAt","author_url":"https:\/\/drnat.com\/nd\/author\/NAt\/","title":"Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. - Dr. Nathan Ehrlich, N.D.","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"sr9YzVVpKU\"><a href=\"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/\">Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial.<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/embed\/#?secret=sr9YzVVpKU\" width=\"600\" height=\"338\" title=\"&#8220;Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial.&#8221; &#8212; Dr. Nathan Ehrlich, N.D.\" data-secret=\"sr9YzVVpKU\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"Sci Rep.&nbsp;2017 Dec;7(1):94. doi: 10.1038\/s41598-017-00224-6. Epub 2017 Mar 7. Wu YT1,2,&nbsp;Ho TY1,&nbsp;Chou YC3,&nbsp;Ke MJ1,&nbsp;Li TY1,2,&nbsp;Huang GS4,&nbsp;Chen LC5. Author information Abstract Recently, a few small reports with short follow-up period have shown clinical benefits of platelet-rich plasma (PRP) for peripheral neuropathy including one pilot study and one small, non-randomized trial in patients with&nbsp;carpal tunnel syndrome&nbsp;(CTS). Therefore, [&hellip;]"}